Cullen Investment Group LTD. Has $3.81 Million Stake in McKesson Corporation $MCK

Cullen Investment Group LTD. grew its position in McKesson Corporation (NYSE:MCK) by 550.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,670 shares of the company’s stock after purchasing an additional 3,952 shares during the period. Cullen Investment Group LTD.’s holdings in McKesson were worth $3,811,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of the company. GGM Financials LLC bought a new stake in McKesson in the 3rd quarter valued at approximately $25,000. State of Wyoming bought a new position in shares of McKesson during the 2nd quarter worth approximately $29,000. Hopwood Financial Services Inc. acquired a new stake in shares of McKesson in the third quarter valued at approximately $31,000. Board of the Pension Protection Fund acquired a new stake in shares of McKesson in the fourth quarter valued at approximately $33,000. Finally, Vermillion & White Wealth Management Group LLC bought a new stake in shares of McKesson in the third quarter worth $33,000. 85.07% of the stock is owned by institutional investors and hedge funds.

McKesson Trading Down 0.3%

NYSE MCK opened at $879.57 on Thursday. The firm has a market capitalization of $107.74 billion, a P/E ratio of 25.30, a price-to-earnings-growth ratio of 1.42 and a beta of 0.38. The firm’s fifty day moving average price is $906.79 and its two-hundred day moving average price is $837.49. McKesson Corporation has a 1 year low of $637.00 and a 1 year high of $999.00.

McKesson (NYSE:MCK) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. The company had revenue of $106.16 billion during the quarter, compared to the consensus estimate of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The company’s quarterly revenue was up 11.4% on a year-over-year basis. During the same quarter last year, the firm posted $8.03 EPS. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, research analysts anticipate that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be issued a dividend of $0.82 per share. The ex-dividend date is Monday, March 2nd. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. McKesson’s dividend payout ratio (DPR) is presently 9.43%.

Insider Activity

In other McKesson news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the company’s stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $955.00, for a total value of $313,240.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Thomas L. Rodgers sold 276 shares of the firm’s stock in a transaction that occurred on Monday, January 5th. The shares were sold at an average price of $816.18, for a total value of $225,265.68. Following the completion of the sale, the executive vice president directly owned 2,268 shares of the company’s stock, valued at approximately $1,851,096.24. The trade was a 10.85% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 3,868 shares of company stock valued at $3,743,820. 0.08% of the stock is owned by insiders.

Analysts Set New Price Targets

Several brokerages recently commented on MCK. Wells Fargo & Company increased their target price on shares of McKesson from $914.00 to $925.00 and gave the stock an “equal weight” rating in a report on Thursday, February 5th. Evercore reissued an “outperform” rating on shares of McKesson in a research report on Thursday, March 5th. Weiss Ratings downgraded shares of McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a research note on Thursday, February 5th. Robert W. Baird set a $968.00 target price on McKesson in a research report on Wednesday, January 14th. Finally, Raymond James Financial set a $970.00 target price on McKesson in a report on Thursday, March 5th. Thirteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, McKesson currently has a consensus rating of “Moderate Buy” and a consensus target price of $960.93.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.